tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tango Therapeutics Adds Independent Director to Strengthen Governance
PremiumCompany AnnouncementsTango Therapeutics Adds Independent Director to Strengthen Governance
2M ago
Strategic Positioning and Synergy Potential Drive Buy Rating for Tango Therapeutics’ Vopimetostat
Premium
Ratings
Strategic Positioning and Synergy Potential Drive Buy Rating for Tango Therapeutics’ Vopimetostat
3M ago
Tango Therapeutics initiated with a Buy at Stifel
Premium
The Fly
Tango Therapeutics initiated with a Buy at Stifel
3M ago
Tango Therapeutics price target raised to $14 from $8 at B. Riley
PremiumThe FlyTango Therapeutics price target raised to $14 from $8 at B. Riley
3M ago
Tango Therapeutics initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Tango Therapeutics initiated with a Peer Perform at Wolfe Research
3M ago
Tango Therapeutics Reports Promising Q3 2025 Results
Premium
Company Announcements
Tango Therapeutics Reports Promising Q3 2025 Results
4M ago
Tango Therapeutics’ Promising Update on TNG260 Clinical Study
PremiumCompany AnnouncementsTango Therapeutics’ Promising Update on TNG260 Clinical Study
4M ago
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors
Premium
Company Announcements
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors
4M ago
Tango Therapeutics price target raised to $12 from $10 at Guggenheim
Premium
The Fly
Tango Therapeutics price target raised to $12 from $10 at Guggenheim
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100